Studiet 1 var et enkelt- arm studie med 54 patienter med recidiverende follikulære lymfomer, der er refraktære over for rituximab- behandling.
Study 1 was a single arm study of 54 patients with relapsed follicular lymphoma refractory to rituximab treatment.